000 | 01945 a2200541 4500 | ||
---|---|---|---|
005 | 20250518010939.0 | ||
264 | 0 | _c20190610 | |
008 | 201906s 0 0 eng d | ||
022 | _a1471-2261 | ||
024 | 7 |
_a10.1186/s12872-018-0947-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _avon Känel, Roland | |
245 | 0 | 0 |
_aAssociation of sleep problems with neuroendocrine hormones and coagulation factors in patients with acute myocardial infarction. _h[electronic resource] |
260 |
_bBMC cardiovascular disorders _c11 2018 |
||
300 |
_a213 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcute Coronary Syndrome _xblood |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aBlood Coagulation Factors _xanalysis |
650 | 0 | 4 |
_aEpinephrine _xblood |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrin Fibrinogen Degradation Products _xanalysis |
650 | 0 | 4 |
_aFibrinogen _xanalysis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydrocortisone _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeurotransmitter Agents _xblood |
650 | 0 | 4 |
_aNon-ST Elevated Myocardial Infarction _xblood |
650 | 0 | 4 |
_aNorepinephrine _xblood |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aST Elevation Myocardial Infarction _xblood |
650 | 0 | 4 | _aSleep |
650 | 0 | 4 |
_aSleep Apnea, Obstructive _xblood |
650 | 0 | 4 |
_aSleep Initiation and Maintenance Disorders _xcomplications |
650 | 0 | 4 |
_avon Willebrand Factor _xanalysis |
700 | 1 | _aPrincip, Mary | |
700 | 1 | _aSchmid, Jean-Paul | |
700 | 1 | _aBarth, Jürgen | |
700 | 1 | _aZnoj, Hansjörg | |
700 | 1 | _aSchnyder, Ulrich | |
700 | 1 | _aMeister-Langraf, Rebecca E | |
773 | 0 |
_tBMC cardiovascular disorders _gvol. 18 _gno. 1 _gp. 213 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12872-018-0947-5 _zAvailable from publisher's website |
999 |
_c29078097 _d29078097 |